Total Payments
$131,937
2024 Payments
$18,844
Companies
30
Transactions
469
Medicare Patients
11,575
Medicare Billing
$1.2M
Payment Breakdown by Category
Other$99,469 (75.4%)
Travel$16,394 (12.4%)
Food & Beverage$12,282 (9.3%)
Consulting$3,600 (2.7%)
Education$191.62 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $99,469 | 37 | 75.4% |
| Travel and Lodging | $16,394 | 29 | 12.4% |
| Food and Beverage | $12,282 | 391 | 9.3% |
| Consulting Fee | $3,600 | 5 | 2.7% |
| Education | $191.62 | 7 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $63,789 | 63 | $0 (2024) |
| Genentech USA, Inc. | $38,955 | 63 | $0 (2024) |
| Shire North American Group Inc | $18,530 | 53 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $3,345 | 16 | $0 (2019) |
| GENZYME CORPORATION | $1,497 | 16 | $0 (2024) |
| CSL Behring | $1,212 | 49 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $1,054 | 41 | $0 (2023) |
| GlaxoSmithKline, LLC. | $975.57 | 52 | $0 (2023) |
| PFIZER INC. | $463.92 | 29 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $334.66 | 11 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18,844 | 22 | Takeda Pharmaceuticals U.S.A., Inc. ($18,713) |
| 2023 | $29,593 | 68 | Takeda Pharmaceuticals U.S.A., Inc. ($28,367) |
| 2022 | $7,185 | 41 | Takeda Pharmaceuticals U.S.A., Inc. ($5,013) |
| 2021 | $11,650 | 24 | Takeda Pharmaceuticals U.S.A., Inc. ($6,398) |
| 2020 | $6,471 | 7 | Takeda Pharmaceuticals U.S.A., Inc. ($5,298) |
| 2019 | $31,051 | 110 | Shire North American Group Inc ($17,780) |
| 2018 | $11,296 | 104 | Genentech USA, Inc. ($9,685) |
| 2017 | $15,845 | 93 | Genentech USA, Inc. ($13,997) |
All Payment Transactions
469 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $31.38 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Travel and Lodging | In-kind items and services | $150.00 | General |
| 10/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,575.00 | General |
| 10/01/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $81.60 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 09/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Travel and Lodging | In-kind items and services | $50.00 | General |
| 09/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Travel and Lodging | In-kind items and services | $1,099.01 | General |
| 09/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $75.00 | General |
| 09/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Travel and Lodging | In-kind items and services | $50.00 | General |
| 09/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,675.00 | General |
| 09/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $33.57 | General |
| Category: IMMUNOLOGY | ||||||
| 09/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,675.00 | General |
| 08/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Travel and Lodging | In-kind items and services | $1,617.44 | General |
| 08/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $123.02 | General |
| 08/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: IMMUNOLOGY | ||||||
| 08/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Travel and Lodging | In-kind items and services | $999.42 | General |
| 08/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $121.45 | General |
| 03/27/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: Immunology | ||||||
| 03/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Immunology | ||||||
| 03/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $27.40 | General |
| Category: IMMUNOLOGY | ||||||
| 03/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $4.19 | General |
| Category: IMMUNOLOGY | ||||||
| 02/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: IMMUNOLOGY | ||||||
| 02/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $3.68 | General |
| Category: RESPIRATORY | ||||||
| 12/01/2023 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Inflammation | ||||||
| 11/16/2023 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,675.00 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 2,810 | 4,331 | $540,507 | $182,822 |
| 2022 | 13 | 2,537 | 11,959 | $1.1M | $403,837 |
| 2021 | 14 | 2,991 | 4,374 | $555,448 | $192,739 |
| 2020 | 16 | 3,237 | 13,367 | $1.2M | $460,109 |
Total Patients
11,575
Total Services
34,031
Medicare Billing
$1.2M
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 556 | 1,019 | $269,338 | $91,836 | 34.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 183 | 183 | $63,491 | $20,643 | 32.5% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 528 | 542 | $62,603 | $20,557 | 32.8% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 527 | 541 | $60,227 | $20,221 | 33.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 447 | 448 | $35,708 | $12,376 | 34.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 32 | 32 | $14,671 | $4,751 | 32.4% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 142 | 169 | $9,340 | $3,099 | 33.2% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 19 | 902 | $7,819 | $2,722 | 34.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 179 | 264 | $4,503 | $2,213 | 49.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 34 | $6,356 | $2,181 | 34.3% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 123 | 148 | $5,690 | $1,850 | 32.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 48 | 49 | $761.46 | $372.89 | 49.0% |
| J2357 | Injection, omalizumab, 5 mg | Office | 2022 | 12 | 7,761 | $584,999 | $232,379 | 39.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 595 | 964 | $257,236 | $86,977 | 33.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 205 | 205 | $72,481 | $23,617 | 32.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 393 | 402 | $48,664 | $16,185 | 33.3% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 392 | 401 | $45,431 | $15,527 | 34.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 343 | 344 | $27,897 | $9,854 | 35.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 37 | 37 | $17,306 | $6,060 | 35.0% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 12 | 78 | $12,426 | $3,984 | 32.1% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 24 | 1,160 | $10,324 | $3,590 | 34.8% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 145 | 154 | $8,641 | $2,827 | 32.7% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2022 | 117 | 120 | $4,738 | $1,534 | 32.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 196 | 266 | $1,596 | $788.85 | 49.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 66 | 67 | $1,041 | $515.15 | 49.5% |
About Dr. Usha Chandrahasa, MD
Dr. Usha Chandrahasa, MD is a Allergy & Immunology healthcare provider based in Port Charlotte, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1548254857.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Usha Chandrahasa, MD has received a total of $131,937 in payments from pharmaceutical and medical device companies, with $18,844 received in 2024. These payments were reported across 469 transactions from 30 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($99,469).
As a Medicare-enrolled provider, Chandrahasa has provided services to 11,575 Medicare beneficiaries, totaling 34,031 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy & Immunology
- Location Port Charlotte, FL
- Active Since 09/01/2005
- Last Updated 09/08/2021
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1548254857
Products in Payments
- CUVITRU (Biological) $40,412
- Xolair (Biological) $38,481
- HYQVIA (Biological) $24,328
- DUPIXENT (Biological) $1,774
- Hizentra (Biological) $995.25
- TRELEGY ELLIPTA (Drug) $462.89
- EUCRISA (Drug) $429.05
- BEVESPI AEROSPHERE (Drug) $277.22
- TEZSPIRE (Biological) $235.76
- Haegarda (Biological) $216.37
- Dymista (Drug) $208.96
- XOLAIR (Biological) $176.29
- RUCONEST (Biological) $175.96
- SYMBICORT (Drug) $174.13
- NUCALA (Biological) $133.50
- Prolastin-C (Biological) $125.35
- CINRYZE (Drug) $125.00
- AREXVY (Drug) $124.99
- FASENRA (Drug) $110.70
- RESLIZUMAB (Drug) $99.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.